A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4823-4828

  Singh, Mahender ^a   Cattaneo, Roberto ^a   Billeter, Martin A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

EID: 0032994153     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4823-4828.1999     Document Type: Article

References (34)

1. Albrecht, P., K. Herrmann, and G. R. Burns. 1981. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3:251-260.
2. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-688.
3. Cattaneo, R., H. Will, G. Darai. E. Pfaff, and H. Schaller. 1983. Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells. EMBO J. 2:511-514.
4. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
5. Cornu, T. 1997. Use of measles virus as a vector: stable expression of a supplementary large transcription unit or additional foreign viral glycoproteins. M.S. thesis. University of Zurich, Zurich, Switzerland.
6. Davis, A. R., B. Kostek, B. B. Mason, C. L. Hsiao, J. Morin, S. K. Dheer, and F. P. Hung. 1985. Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc. Natl. Acad. Sci. USA 82:7560-7564.
7. Dörig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305.
8. Ellis, R. W. 1990. New and improved vaccines against hepatitis B, p. 439-447. In G. Woodrow and M. Levine (ed.), New generation vaccines. Marcel Dekker, New York, N.Y.
9. Gallbert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
10. Griffin, D. E., and W. J. Bellini. 1996. Measles virus, p. 1267-1312. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa.
11. Hangartner, L. 1997. Development of measles virus as a vector: expression of green fluorescent protein from different loci. M.S. thesis. University of Zurich, Zurich, Switzerland.
12. Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 52:396-402.
13. Hilleman, M. R., W. J. McAleer, E. B. Buynak, and A. A. McLean. 1983. The preparation and safety of hepatitis B vaccine. J. Infect. 7:3-8.
14. Hollinger, F. B. 1996. Hepatitis B virus, p. 2739-2807. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
15. Hussey, G. D., E. A. Goddard, J. Hughes, J. J. Ryon, M. Kerran, E. Carelse, P. M. Strebel, L. E. Markowitz, J. Moodie, P. Barron, Z. Latief, R. Sayed, D. Beatty, and D. E. Griffin. 1996. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants. J. Infect. Dis. 173:1320-1326.
16. Kärber, G. 1931. Beitrag zur Kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480-483.
17. MacKay, P., M. Pasek, M. Magazin, R. T. Kovacic, B. Allet, S. Stahl, W. Gilbert, H. Schaller, S. A. Bruce, and K. Murray. 1981. Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli. Proc. Natl. Acad. Sci. USA 78:4510-4514.
18. Mann, G. F., L. M. Allison, J. A. Copeland, C. F. Agostini, and A. J. Zuckerman. 1980. A simplified plaque assay system for measles virus. J. Biol. Stand. 8:219-225.
19. McAleer, W. J., E. B. Buynak, R. Z. Maigetter, D. E. Wampler, W. J. Miller, and M. R. Hilleman. 1984. Human hepatitis B vaccine from recombinant yeast. Nature 307:178-180.
20. Mrkic, B., J. Pavlovic, T. Rülicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
21. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
22. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, G. Christiansen, M. Huber, C. Dötsch, and M. A. Billeter. 1995. Rescue of infectious measles viruses from cloned DNA. EMBO J. 14:5773-5784.
23. Riley, E. C., G. Murphy, and R. L. Riley. 1978. Airborne spread of measles in a suburban elementary school. Am. J. Epidemiol. 107:421-432.
24. Rusconi, S., Y. Severne, O. Georgiev, I. Galli, and S. Wieland. 1990. A novel expression assay to study transcriptional activators. Gene 89:211-221.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Schneider, H., K. Kaelin, and M. A. Billeter. 1997. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227:314-322.
27. Seifer, M., and D. N. Standring. 1995. Assembly and antigenicity of hepatitis B virus core particles. Intervirology 38:47-62.
28. Singh, M., and M. A. Billeter. 1998. A recombinant measles virus expressing biologically active human interleukin-12. J. Gen. Virol. 80:101-106.
29. Singh, M., L. Hangartner, T. Cornu, G. Christiansen, and M. A. Billeter. 1997. Measles virus as a vector system, abstr. 102, p. 101. In Abstracts of the 10th International Conference on Negative Strand Viruses.
30. Spielhofer, P. 1995. Generation of standard, variant and chimeric measles viruses from cloned DNA. Ph.D. thesis. University of Zurich, Zurich, Switzerland.
31. Szmuness, W., C. E. Stevens, E. A. Zang, E. J. Harley, and A. Kellner. 1981. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1:377-385.
32. World Health Organization Website. October 1996, copyright date. [Online.] Hepatitis B vaccine. httpy/www.who.ch/gpv-documents/Newslets/H3Updat.htm. [30 March 1999, last date accessed.]
33. Yap, I., R. Guan, and S. H. Chan. 1992. Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - a preliminary study on immunogenicity. Vaccine 10:439-442.
34. Yuasa, T., K. Kajino, I. Saito, and T. Miyamura. 1991. Preferential expression of the large hepatitis B virus surface antigen gene by an adenovirus-hepatitis B virus recombinant. J. Gen. Virol. 72:1927-1934.